Hepatic insulin resistance diminishes the ability of insulin to suppress gluconeogenesis and promotes de novo lipogenesis, driving lipid accumulation and pro-inflammatory signaling in hepatocytes ( Hepatic inflammation and fibrosis further aggravate systemic insulin resistance through the release of hepatokines such as fetuin-A and FGF21, which impair insulin signaling in peripheral tissues ( Given this mechanistic interdependence, the liver-pancreas axis represents an important therapeutic target
Semaglutide, through its innovative mechanism of action that mimics the natural incretin hormone GLP-1, offers not just improved glycemic control but also significant weight loss benefits, a combination that has been elusive in diabetes management for decades
More study results are expected in 2026, and it could potentially be approved as early as 2027
Avoid injecting into areas that have scars or irritated skin
Pharmaceutical companies across the US, Europe, Latin America, and emerging markets are actively seeking reliable partners for high-quality GLP-1 APIs
Which syringe types are commonly used for peptide injections